ESPU Congress 2018 - Abstract Book

147 11–14 APRIL, 2018, HELSINKI, FINLAND CONCLUSIONS Bladder capacity in PUV, either normal or abnormal, does not affect bladder emptying and does not correlate with renal impairment. 1 Austin PF et al. J Urol 2014; 191: 1863–1865 16:08–16:23 Discussion 16:23–16:26 S19-6 (PP) PRELIMINARY EXPERIENCE WITH INSTILLATION OF TRIAMCINOLONE ACETONIDE INTO THE URETHRA FOR IDIOPATHIC URETHRITIS: A PROSPECTIVE PILOT STUDY Junaid ASHRAF, Anna RADFORD, Alexander TURNER and Ramnath SUBRAMANIAM Leeds Children's Hospital, Department of Paediatric Urology, Leeds, UNITED KINGDOM PURPOSE Idiopathic Bulbar Urethritis (IBU) is characterised by haematuria +/- dysuria without infection. Symptoms result from inflammation of the bulbar urethra, distal to external sphincter. IBU is difficult to manage and there is no recommended therapy. The aim of the study was to determine whether instillation of triamcinolone acetonide is a useful treatment of IBU and its’ associated complications. MATERIAL AND METHODS Data was prospectively collected, for 38 months, on 28 consecutive patients presenting with terminal haematuria or blood spotting +/- dysuria to a paediatric urology unit. Visual confirmation of IBU was obtained cystoscopically and 80 mg of triamcinolone was instilled to the inflamed area under direct vision using an open-ended ureteral catheter. Follow-up telephone interviews, to assess symptom persistence and side-effects, were performed at six weeks post-intervention. Symptoms resolution was the primary outcome. Repeat cystoscopic assessment +/- triamcinolone instillation was recorded, as was the occurrence of complications. RESULTS Median age 12 years (range: 9–16). Mean symptom duration 16 months (range: 6–30). Normal baseline laboratory blood tests, urine cultures and ultrasound assessments were seen in all; therefore, none were excluded on the basis of a known pathology. The mean follow-up period was 28 months (range: 4–42). 12 patients (42.85 %) required at least one further treatment. Overall complete or partial resolution was reported in 21/28 (75 %). No side effects were reported. CONCLUSIONS This prospective series demonstrates that intra-urethral instillation of triamcinolone seems to be promising treatment option to alleviate inflammatory symptoms in majority of cases of idiopathic urethritis.